SCHEMBL28045441

SCHEMBL28045441

COCCNCc1cncc(NC(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 3/20 0.39
▸ CD274 Q9NZQ7 3/20 0.39
▸ NAMPT P43490 3/20 0.39
▸ CHEK1 O14757 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ TBK1 Q9UHD2 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HTR5A P47898 1/20 0.36
▸ BRAF P15056 1/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15971513 0.84 NAMPT (0.42) PDCD1CD274NAMPTCHEK1
SCHEMBL15986863 0.78 L3MBTL1 (0.44) PDCD1CD274NAMPTALDH1A1L3MBTL1
SCHEMBL112780 0.74 L3MBTL1 (0.43) ALDH1A1L3MBTL1KDM4ESMN1; SMN2BRAF
SCHEMBL13280071 0.74 L3MBTL1 (0.43) PDCD1CD274CHEK1ALDH1A1L3MBTL1
SCHEMBL27961472 0.73 PDCD1 (0.42) PDCD1CD274NAMPTALDH1A1KDM4E
SCHEMBL17161607 0.73 SCN10A (0.43) NAMPTALDH1A1L3MBTL1KDM4ECYP2C9
SCHEMBL13466389 0.71 L3MBTL1 (0.59) CD274CHEK1L3MBTL1TBK1BRAF
SCHEMBL25328772 0.71 CNR1 (0.37) NAMPTALDH1A1L3MBTL1KDM4ECYP2C9
SCHEMBL30635459 0.71 L3MBTL1 (0.49) PDCD1CD274ALDH1A1L3MBTL1CYP2C9
SCHEMBL25329428 0.71 NPC1 (0.42) NAMPTALDH1A1KDM4ECYP2C9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105189480-A Pyrimidine compounds useful in the treatment of disorders mediated by the IKK and/or TBK-1 mechanism DOMAINEX LTD 2015-12-23 — — CN disclosed
Send feedback